Mark Elliott Boulding
EXEC. VP AND CLO at PTC Therapeutics. Based in Warren, New Jersey.
- Rank
- 12560th of 14,644
- Companies held
- 1
- Largest holding
- PTCT, 100.0% of total
- Latest SEC filing
- Nov 16, 2026
What the $6.1M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| PTC Therapeutics PTCT Common Stock | Directly | 105,272 | $58.33 | $6.1M | 100.0% | Form 4, Nov 16, 2026 |
Share counts are the amounts Mark Elliott Boulding reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Sold | PTCT | 1,315 | $61.39 | $81K | View |
| Nov 16, 2026 | Sold | PTCT | 1,288 | $62.22 | $80K | View |
| Nov 16, 2026 | Sold | PTCT | 209 | $62.90 | $13K | View |
| Oct 9, 2026 | Sold | PTCT | 192 | $64.26 | $12K | View |
| Oct 6, 2026 | Sold | PTCT | 435 | $64.16 | $28K | View |
| Oct 5, 2026 | Sold | PTCT | 1,638 | $64.03 | $105K | View |
| Aug 17, 2026 | Sold | PTCT | 969 | $72.90 | $71K | View |
| Aug 17, 2026 | Sold | PTCT | 1,844 | $72.39 | $133K | View |
| Jul 6, 2026 | Sold | PTCT | 833 | $84.41 | $70K | View |
| Jul 6, 2026 | Sold | PTCT | 313 | $83.10 | $26K | View |
| Jul 6, 2026 | Sold | PTCT | 745 | $86.38 | $64K | View |
| Jul 6, 2026 | Sold | PTCT | 519 | $85.84 | $45K | View |
| Jul 6, 2026 | Sold | PTCT | 1,036 | $84.41 | $87K | View |
| Jul 6, 2026 | Sold | PTCT | 387 | $83.10 | $32K | View |
| Jul 6, 2026 | Sold | PTCT | 601 | $86.38 | $52K | View |
| Jul 6, 2026 | Sold | PTCT | 645 | $85.84 | $55K | View |
| Jun 17, 2026 | Sold | PTCT | 1,850 | $79.24 | $147K | View |
| Jun 17, 2026 | Sold | PTCT | 1,703 | $78.50 | $134K | View |
| Jun 17, 2026 | Sold | PTCT | 309 | $79.25 | $24K | View |
| Jun 17, 2026 | Sold | PTCT | 6,600 | $78.50 | $518K | View |
| May 15, 2026 | Sold | PTCT | 456 | $72.67 | $33K | View |
| May 15, 2026 | Sold | PTCT | 2,356 | $72.08 | $170K | View |
| May 8, 2026 | Sold | PTCT | 840 | $78.23 | $66K | View |
| May 8, 2026 | Sold | PTCT | 1,900 | $79.31 | $151K | View |
| May 8, 2026 | Sold | PTCT | 200 | $78.00 | $16K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 12557 | James Cullen Director, Keysight Technologies. Santa Rosa, CA | $6.1M |
| 12558 | Bradford T. Nordholm Chief Executive Officer, Federal Agricultural Mortgage. Washington, DC | $6.1M |
| 12559 | R. Steven Hamner Executive Vice President & CFO, Medical Properties Trust. Birmingham, AL | $6.1M |
| 12560 | Mark Elliott Boulding EXEC. VP AND CLO, PTC Therapeutics. Warren, NJ | $6.1M |
| 12561 | Joseph J. Beacom President of LSHI, Landstar System. Jacksonville, FL | $6.1M |
| 12562 | Emily Luisa Hill Chief Financial Officer, Replimune Group. Woburn, MA | $6.1M |
| 12563 | Sunil Cutinho Chief Information Officer, CME Group. Chicago, IL | $6.1M |
Other PTC Therapeutics insiders
All PTCT insiders- Matthew B. Klein$22.4MCHIEF EXECUTIVE OFFICER. #4707 overall
- Stuart Walter Peltz$15.2MCHIEF EXECUTIVE OFFICER. #6376 overall
- Michael Schmertzler$9.5MDirector. #2219 overall
- Pierre Gravier$4.9MCHIEF FINANCIAL OFFICER. #14568 overall
- Emily Luisa Hill$2.3MCHIEF FINANCIAL OFFICER. #12562 overall
Questions
How much stock does Mark Elliott Boulding own?
Mark Elliott Boulding holds $6,139,989 in listed stock based on SEC filings and current prices, mostly PTC Therapeutics (PTCT). That ranks 12560th on the Stock Rich List.
Is this Mark Elliott Boulding's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Mark Elliott Boulding last buy or sell stock?
The most recent open-market trade on file is a sale of 1,315 PTCT shares on Nov 16, 2026 at $61.39.